{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:11:44Z","timestamp":1785435104114,"version":"3.56.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG53036"],"award-info":[{"award-number":["AG53036"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG17586"],"award-info":[{"award-number":["AG17586"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG10224"],"award-info":[{"award-number":["AG10224"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS088341"],"award-info":[{"award-number":["NS088341"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0687-5","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T15:03:06Z","timestamp":1551711786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Detection of Alzheimer\u2019s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)"],"prefix":"10.1186","volume":"7","author":[{"given":"Garrett S.","family":"Gibbons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Changolkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia M.-Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"687_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496\u2013503","journal-title":"Neurology"},{"key":"687_CR2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/01.wnl.0000311445.21321.fc","volume":"70","author":"H Bian","year":"2008","unstructured":"Bian H, Van Swieten JC, Leight S, Massimo L, Wood E, Forman M et al (2008) CSF biomarkers in frontotemporal lobar degeneration with known pathology. Neurology 70:1827\u20131835","journal-title":"Neurology"},{"key":"687_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00401-013-1089-6","volume":"125","author":"EH Bigio","year":"2013","unstructured":"Bigio EH, Wu JY, Deng HX, Bit-Ivan EN, Mao Q, Ganti R et al (2013) Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol 125:463\u2013465","journal-title":"Acta Neuropathol"},{"key":"687_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","volume":"101","author":"LI Binder","year":"1985","unstructured":"Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101:1371\u20131378","journal-title":"J Cell Biol"},{"key":"687_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"687_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"687_CR8","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/brain\/awl269","volume":"129","author":"K Buerger","year":"2006","unstructured":"Buerger K, Ewers M, Pirttila T, Zinkowski R, Alafuzoff I, Teipel SJ et al (2006) CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. Brain 129:3035\u20133041","journal-title":"Brain"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I et al (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755\u2013766","journal-title":"Acta Neuropathol"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/jnnp.2010.207183","volume":"82","author":"LC de Souza","year":"2011","unstructured":"de Souza LC, Lamari F, Belliard S, Jardel C, Houillier C, De Paz R et al (2011) Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. J Neurol Neurosurg Psychiatry 82:240\u2013246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","volume":"103","author":"DG Drubin","year":"1986","unstructured":"Drubin DG, Kirschner MW (1986) Tau protein function in living cells. J Cell Biol 103:2739\u20132746","journal-title":"J Cell Biol"},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","volume":"129","author":"C Duyckaerts","year":"2015","unstructured":"Duyckaerts C, Braak H, Brion JP, Buee L, Del Tredici K, Goedert M et al (2015) PART is part of Alzheimer disease. Acta Neuropathol 129:749\u2013756","journal-title":"Acta Neuropathol"},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-2008-14101","volume":"14","author":"M Espinoza","year":"2008","unstructured":"Espinoza M, de Silva R, Dickson DW, Davies P (2008) Differential incorporation of tau isoforms in Alzheimer's disease. J Alzheimer's Dis : JAD 14:1\u201316","journal-title":"J Alzheimer's Dis : JAD"},{"key":"687_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archneurol.2011.105","volume":"68","author":"AM Fagan","year":"2011","unstructured":"Fagan AM, Shaw LM, Xiong C, Vanderstichele H, Mintun MA, Trojanowski JQ et al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of beta-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 68:1137\u20131144","journal-title":"Arch Neurol"},{"key":"687_CR15","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.20873","volume":"59","author":"MS Forman","year":"2006","unstructured":"Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB et al (2006) Frontotemporal dementia: clinicopathological correlations. Ann Neurol 59:952\u2013962","journal-title":"Ann Neurol"},{"key":"687_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awx328","volume":"141","author":"SL Forrest","year":"2017","unstructured":"Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS et al (2017) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521\u2013534","journal-title":"Brain"},{"key":"687_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/archneur.55.7.937","volume":"55","author":"D Galasko","year":"1998","unstructured":"Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D et al (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55:937\u2013945","journal-title":"Arch Neurol"},{"key":"687_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/jnen\/nly010","volume":"77","author":"GS Gibbons","year":"2018","unstructured":"Gibbons GS, Banks RA, Kim B, Changolkar L, Riddle DM, Leight SN et al (2018) Detection of Alzheimer disease (AD)-specific tau pathology in AD and NonAD Tauopathies by immunohistochemistry with novel conformation-selective tau antibodies. J Neuropathol Exp Neurol 77:216\u2013228","journal-title":"J Neuropathol Exp Neurol"},{"key":"687_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-neuro-072116-031153","volume":"40","author":"M Goedert","year":"2017","unstructured":"Goedert M, Eisenberg DS, Crowther RA (2017) Propagation of tau aggregates and neurodegeneration. Annu Rev Neurosci 40:189\u2013210","journal-title":"Annu Rev Neurosci"},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","volume":"8","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393\u2013399","journal-title":"EMBO J"},{"key":"687_CR21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","volume":"267","author":"SG Greenberg","year":"1992","unstructured":"Greenberg SG, Davies P, Schein JD, Binder LI (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564\u2013569","journal-title":"J Biol Chem"},{"key":"687_CR22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13073-015-0232-5","volume":"7","author":"R Guerreiro","year":"2015","unstructured":"Guerreiro R, Bras J (2015) The age factor in Alzheimer's disease. Genome Med 7:106","journal-title":"Genome Med"},{"key":"687_CR23","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo JL, Narasimhan S, Changolkar L, He Z, Stieber A, Zhang B et al (2016) Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. J Exp Med 213:2635\u20132654","journal-title":"J Exp Med"},{"key":"687_CR24","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.1021\/bi00198a017","volume":"33","author":"N Gustke","year":"1994","unstructured":"Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E (1994) Domains of tau protein and interactions with microtubules. Biochemistry 33:9511\u20139522","journal-title":"Biochemistry"},{"key":"687_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"687_CR26","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914\u20131917","journal-title":"Science"},{"key":"687_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H et al (1998) Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705","journal-title":"Nature"},{"key":"687_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.24559","volume":"79","author":"DJ Irwin","year":"2016","unstructured":"Irwin DJ, Brettschneider J, McMillan CT, Cooper F, Olm C, Arnold SE et al (2016) Deep clinical and neuropathological phenotyping of pick disease. Ann Neurol 79:272\u2013287","journal-title":"Ann Neurol"},{"key":"687_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","volume":"129","author":"DJ Irwin","year":"2015","unstructured":"Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM et al (2015) Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine. Acta Neuropathol 129:469\u2013491","journal-title":"Acta Neuropathol"},{"key":"687_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ajpath.2013.04.025","volume":"183","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Cohen TJ, Grossman M, Arnold SE, McCarty-Wood E, Van Deerlin VM et al (2013) Acetylated tau neuropathology in sporadic and hereditary tauopathies. Am J Pathol 183:344\u2013351","journal-title":"Am J Pathol"},{"key":"687_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/aws013","volume":"135","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, Cohen TJ, Grossman M, Arnold SE, Xie SX, Lee VM et al (2012) Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain 135:807\u2013818","journal-title":"Brain"},{"key":"687_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","volume":"14","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Lee VM, Trojanowski JQ (2013) Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat Rev Neurosci 14:626\u2013636","journal-title":"Nat Rev Neurosci"},{"key":"687_CR33","doi-asserted-by":"crossref","unstructured":"Irwin DJ, Lleo A, Xie SX, CT MM, Wolk D, Lee EB et al (2017) Ante mortem CSF tau levels correlate with post mortem tau pathology in FTLD. Ann Neurol 82:247\u2013258","DOI":"10.1002\/ana.24996"},{"key":"687_CR34","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1001\/archneurol.2012.26","volume":"69","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, McMillan CT, Toledo JB, Arnold SE, Shaw LM, Wang LS et al (2012) Comparison of cerebrospinal fluid levels of tau and Abeta 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol 69:1018\u20131025","journal-title":"Arch Neurol"},{"key":"687_CR35","doi-asserted-by":"publisher","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","volume":"90","author":"DJ Irwin","year":"2018","unstructured":"Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT et al (2018) CSF tau and beta-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders. Neurology 90:e1038\u2013e1e46","journal-title":"Neurology"},{"key":"687_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128\u2013132","journal-title":"J Neurosci Res"},{"key":"687_CR37","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","volume":"69","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Lane E, Vincent I, Otvos L Jr, Hoffmann R, Davies P (1997) A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J Neurochem 69:2087\u20132095","journal-title":"J Neurochem"},{"key":"687_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2990.1989.tb01255.x","volume":"15","author":"C Lamy","year":"1989","unstructured":"Lamy C, Duyckaerts C, Delaere P, Payan C, Fermanian J, Poulain V et al (1989) Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol 15:563\u2013578","journal-title":"Neuropathol Appl Neurobiol"},{"key":"687_CR39","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159","journal-title":"Annu Rev Neurosci"},{"key":"687_CR40","first-page":"232","volume":"10","author":"L Lemoine","year":"2018","unstructured":"Lemoine L, Leuzy A, Chiotis K, Rodriguez-Vieitez E, Nordberg A (2018) Tau positron emission tomography imaging in tauopathies: the added hurdle of off-target binding. Alzheimers Dement 10:232\u2013236","journal-title":"Alzheimers Dement"},{"key":"687_CR41","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1073\/pnas.92.22.10369","volume":"92","author":"P LoPresti","year":"1995","unstructured":"LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S A 92:10369\u201310373","journal-title":"Proc Natl Acad Sci U S A"},{"key":"687_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"687_CR43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1097\/00005072-199912000-00002","volume":"58","author":"JR Murrell","year":"1999","unstructured":"Murrell JR, Spillantini MG, Zolo P, Guazzelli M, Smith MJ, Hasegawa M et al (1999) Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. J Neuropathol Exp Neurol 58:1207\u20131226","journal-title":"J Neuropathol Exp Neurol"},{"key":"687_CR44","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/JNEUROSCI.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan S, Guo JL, Changolkar L, Stieber A, McBride JD, Silva LV et al (2017) Pathological tau strains from human brains recapitulate the diversity of Tauopathies in nontransgenic mouse brain. J Neurosci 37:11406\u201311423","journal-title":"J Neurosci"},{"key":"687_CR45","doi-asserted-by":"publisher","first-page":"R741","DOI":"10.1016\/j.cub.2012.07.024","volume":"22","author":"T Niccoli","year":"2012","unstructured":"Niccoli T, Partridge L (2012) Ageing as a risk factor for disease. Curr Biol : CB 22:R741\u2013R752","journal-title":"Curr Biol : CB"},{"key":"687_CR46","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele R, Rabinovici GD, Smith R, Cho H, Scholl M, Strandberg O et al (2018) Discriminative accuracy of [F-18] flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders. Jama-J Am Med Assoc 320:1151\u20131162","journal-title":"Jama-J Am Med Assoc"},{"key":"687_CR47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jnr.490390607","volume":"39","author":"L Otvos Jr","year":"1994","unstructured":"Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669\u2013673","journal-title":"J Neurosci Res"},{"key":"687_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ana.10140","volume":"51","author":"SM Rosso","year":"2002","unstructured":"Rosso SM, van Herpen E, Deelen W, Kamphorst W, Severijnen LA, Willemsen R et al (2002) A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease. Ann Neurol 51:373\u2013376","journal-title":"Ann Neurol"},{"key":"687_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-017-0162-3","volume":"12","author":"L Saint-Aubert","year":"2017","unstructured":"Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A (2017) Tau PET imaging: present and future directions. Mol Neurodegener 12:19","journal-title":"Mol Neurodegener"},{"key":"687_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","volume":"78","author":"NS Schoonenboom","year":"2012","unstructured":"Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van de Ven PM et al (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78:47\u201354","journal-title":"Neurology"},{"key":"687_CR51","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Molecular Med 8:595\u2013608","journal-title":"EMBO Molecular Med"},{"key":"687_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC et al (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65:403\u2013413","journal-title":"Ann Neurol"},{"key":"687_CR53","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-015-1503-3","volume":"131","author":"S Taniguchi-Watanabe","year":"2016","unstructured":"Taniguchi-Watanabe S, Arai T, Kametani F, Nonaka T, Masuda-Suzukake M, Tarutani A et al (2016) Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau. Acta Neuropathol 131:267\u2013280","journal-title":"Acta Neuropathol"},{"key":"687_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00401-012-0983-7","volume":"124","author":"JB Toledo","year":"2012","unstructured":"Toledo JB, Brettschneider J, Grossman M, Arnold SE, Hu WT, Xie SX et al (2012) CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathol 124:23\u201335","journal-title":"Acta Neuropathol"},{"key":"687_CR55","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/jnen\/60.12.1123","volume":"60","author":"JQ Trojanowski","year":"2001","unstructured":"Trojanowski JQ, Dickson D (2001) Update on the neuropathological diagnosis of frontotemporal dementias. J Neuropathol Exp Neurol 60:1123\u20131126","journal-title":"J Neuropathol Exp Neurol"},{"key":"687_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/37.2.2492045","volume":"37","author":"JQ Trojanowski","year":"1989","unstructured":"Trojanowski JQ, Schuck T, Schmidt ML, Lee VM (1989) Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytoche 37:209\u2013215","journal-title":"J Histochem Cytoche"},{"key":"687_CR57","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.bbadis.2004.09.010","volume":"1739","author":"M von Bergen","year":"2005","unstructured":"von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E (2005) Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta 1739:158\u2013166","journal-title":"Biochim Biophys Acta"},{"key":"687_CR58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3233\/JAD-2012-120082","volume":"31","author":"LS Wang","year":"2012","unstructured":"Wang LS, Leung YY, Chang SK, Leight S, Knapik-Czajka M, Baek Y et al (2012) Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease. J Alzheimer's Dis : JAD 31:439\u2013445","journal-title":"J Alzheimer's Dis : JAD"},{"key":"687_CR59","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/j.jalz.2010.08.233","volume":"7","author":"SX Xie","year":"2011","unstructured":"Xie SX, Baek Y, Grossman M, Arnold SE, Karlawish J, Siderowf A et al (2011) Building an integrated neurodegenerative disease database at an academic health center. Alzheimer's Dement 7:e84\u2013e93","journal-title":"Alzheimer's Dement"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0687-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T23:49:45Z","timestamp":1663026585000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0687-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0687-5","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were performed with informed consent in accordance with state laws and institutional review board guidelines of the University of Pennsylvania.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"34"}}